ND SB2076

Removes the separate prior authorization exemption rules for individuals under 18 years of age, consolidating medication class protections into a single standard applying to all ages for antipsychotics, antidepressants, anticonvulsants, HIV antiretrovirals, antineoplastics, and transplant immunosuppressants

Eliminates the requirement for prior authorization when minors have five or more concurrent psychotropic prescriptions, along with the mandatory child psychiatrist consultation process for exceeding prescription limits

Creates a new certification program requiring prescribers to annually verify medical necessity for patients with five or more concurrent prescriptions of certain psychiatric medications (antipsychotics, antidepressants, anticonvulsants, benzodiazepines, mood stabilizers, sedative hypnotics, or ADHD medications)

Applies the certification program mandatorily to individuals under age 22, with discretionary application to other individuals by the Department of Health and Human Services

Passed unanimously in both chambers (Senate 46-0, House 92-0)